To transform healthcare, first you have to understand it.


What's new

MFPs beyond Part D: What Maximum Fair Prices mean for Part B stakeholders
With the expansion of the Medicare Drug Price Negotiation Program to include Part B drugs for 2028, stakeholders need to understand the expected impacts.
No Surprises Act – Early results and emerging trends
We analyze publicly available data from the Centers for Medicare and Medicaid Services to evaluate emerging trends in the independent dispute resolution process.

Medicaid managed care financial results for 2025
MCOs experienced a slight underwriting loss for 2025, continuing a trend seen since the end of the COVID-19 public health emergency.

LEAD benchmarking methodology: Implications for ACOs relative to the Medicare Shared Savings Program
The LEAD benchmarking methodology represents a meaningful shift from the Medicare Shared Savings Program, reducing benchmark levels by around $3.2 billion, or 2.3%.
Read the most recent healthcare thought leadership.
Read the articles
How we're helping protect the health and financial well-being of people everywhere
Loading poster...
Walking in Dan's shoes
Gaining Medicaid insights from personal experience.
Loading poster...
MedInsight: Trust your data
We know your decisions are only as good as your data. And your data is only as good as your platform. You can trust the MedInsight platform to get it right.

